We are live on ! Find out more
BIO icon

Bio-Rad Laboratories Class A
BIO

204 hedge funds and large institutions have $2.2B invested in Bio-Rad Laboratories Class A in 2014 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 80 increasing their positions, 57 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

691% more call options, than puts

Call options by funds: $1.8M | Put options by funds: $227K

50% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 22

40% more repeat investments, than reductions

Existing positions increased: 80 | Existing positions reduced: 57

6% more funds holding

Funds holding: 193 → 204 (+11)

1.25% more ownership

Funds ownership: 76.44% → 77.69% (+1.2%)

4% less capital invested

Capital invested by funds: $2.31B → $2.2B (-$101M)

50% less funds holding in top 10

Funds holding in top 10: 4 → 2 (-2)

Holders
204
Holders Change
+11
Holders Change %
+5.7%
% of All Funds
5.86%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.06%
New
33
Increased
80
Reduced
57
Closed
22
Calls
$1.8M
Puts
$227K
Net Calls
+$1.57M
Net Calls Change
+$1.28M

Top Buyers

1
Norges Bank
Norges Bank
Norway
+$18.9M
2
RRAM
River Road Asset Management
Kentucky
+$14.2M
3
TSW
Thompson Siegel & Walmsley
Virginia
+$14M
4
NFA
Nationwide Fund Advisors
Ohio
+$12.2M
5
NIMC
NWQ Investment Management Company
California
+$11M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$24.4M
2
TM
Tikvah Management
North Carolina
-$12.2M
3
KCM
Kennedy Capital Management
Missouri
-$10.9M
4
First Trust Advisors
First Trust Advisors
Illinois
-$8.15M
5
RA
Royce & Associates
New York
-$7.33M
Name Holding Trade Value Shares
Change 		Change in
Stake
ACM
1
Atlanta Capital Management
Georgia
$220M +$4.59M +37,626 +2%
Vanguard Group
2
Vanguard Group
Pennsylvania
$140M +$3.03M +24,811 +2%
AI
3
Ariel Investments
Illinois
$118M -$5.04M -41,277 -4%
LCS
4
Levin Capital Strategies
New York
$114M -$253K -2,068 -0.2%
CIP
5
Champlain Investment Partners
Vermont
$98.9M +$3.22M +26,345 +3%
RA
6
Royce & Associates
New York
$97.3M -$7.33M -60,025 -7%
Wells Fargo
7
Wells Fargo
California
$91M -$198K -1,623 -0.2%
BFA
8
BlackRock Fund Advisors
California
$74.4M +$6.13M +50,199 +9%
UBS AM
9
UBS AM
Illinois
$70.1M -$1.48M -12,096 -2%
BIT
10
BlackRock Institutional Trust
California
$68.8M -$1.65M -13,491 -2%
State Street
11
State Street
Massachusetts
$67.8M +$997K +8,162 +1%
NIMC
12
NWQ Investment Management Company
California
$62.7M +$11M +89,907 +21%
American Century Companies
13
American Century Companies
Missouri
$41.7M +$4.3M +35,181 +11%
RFC
14
Russell Frank Company
Washington
$39.5M +$442K +3,623 +1%
Norges Bank
15
Norges Bank
Norway
$37M +$18.9M +154,412 +100%
MAA
16
Managed Account Advisors
New Jersey
$35.5M +$93.3K +764 +0.3%
Fisher Asset Management
17
Fisher Asset Management
Washington
$35.3M -$5.18M -42,400 -13%
ICM
18
Intrepid Capital Management
Florida
$35.3M +$850K +6,960 +2%
TSW
19
Thompson Siegel & Walmsley
Virginia
$33.6M +$14M +114,991 +69%
GIM
20
Granahan Investment Management
Massachusetts
$32.2M – – –
FWIA
21
Fort Washington Investment Advisors
Ohio
$32.2M +$7.55M +61,797 +30%
Northern Trust
22
Northern Trust
Illinois
$32.2M +$991K +8,112 +3%
FPA
23
First Pacific Advisors
California
$27M – – –
HIM
24
Hermes Investment Management
United Kingdom
$25.7M -$4.38M -35,858 -14%
Bank of New York Mellon
25
Bank of New York Mellon
New York
$24M -$387K -3,170 -2%
1
2 3 4 5

BIO Hedge Fund Activity: Q2 2014 in Review

204 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class A (BIO) for Q2 2014, worth a combined $2.2B — down 4.4% from $2.31B a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new BIO positions and 22 closed out — a net gain of 11 holders — while 80 added to existing stakes and 57 trimmed.

The largest buyer was Norges Bank, adding an estimated $18.9M. The largest seller was Fidelity Investments, cutting an estimated $24.4M.

  • 204 institutional investors held Bio-Rad Laboratories Class A (BIO) as of Q2 2014, up from 193 in Q1 2014.
  • Funds reported $2.2B of Bio-Rad Laboratories Class A stock for Q2 2014, down 4.4% quarter-over-quarter.
  • 33 funds opened new Bio-Rad Laboratories Class A positions in Q2 2014 and 22 closed out, a net change of +11 holders.
  • The largest Bio-Rad Laboratories Class A buyer in Q2 2014 was Norges Bank, an estimated $18.9M added.
  • The largest Bio-Rad Laboratories Class A seller in Q2 2014 was Fidelity Investments, an estimated $24.4M sold.

Based on aggregated 13F filings for Q2 2014.